The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.3% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (8 analysts) rates it buy, with a mean price target of $1408.
Idemitsu Kosan Co.,Ltd.
5019.T · JPX · USD · Market cap $1.98T
Idemitsu Kosan Co.,Ltd.
PASS · Titan EthicalScreen close, 2026-09-23 · not a live quote
Last reviewed 12 days ago
Screened 2026-09-23 · the tape above runs as of 07:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 1,651.00 against the desk's fair-value range, base estimate 1,305.97, over the last year.
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Idemitsu Kosan Co.,Ltd. holds its Markup at $1,651.00. Consolidating, no directional conviction, held for 15 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 15 days |
| Price at the screen | $1,651.00 |
| Valuation | 11.76 trailing · 12.55 forward price to earnings |
| Values screen | PASS |
| Beta | 0.29 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 25.56% | Below 33% | Interest-bearing debt is just 25.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 6.38% | Below 33% | Cash held in interest-bearing accounts and securities is 6.4% of assets, under the one-third limit. | Pass |
| Receivables | 19.78% | Below 49% | Money owed to the company is 19.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.23% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Idemitsu Kosan Co.,Ltd. clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 26%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-23 screen. The gold marker is the market price at the same screen. The price runs 20.9% above the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits −9% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 12.5xcheap for a company growing this fast |
| Trailing P/E | 11.8xreasonably valued |
| EPS, trailing | 140.34 |
| EPS, forward | 131.59 |
| Revenue growth | +23.3%strong top-line growth |
| Profit margin | 4.2%barely profitable |
| Return on equity | 22.5%an exceptional return on shareholder capital |
| Debt to equity | 1.37a meaningful debt load worth watching |
| Current ratio | 1.17adequate liquidity, worth monitoring |
| Beta | 0.29barely tracks the market's swings |
| 52-week range | 987.50 - 1,708.50 |
| Moat | NONE |
| Market cap | $1.98T |
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade5019.T trades on JPX (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.3% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (8 analysts) rates it buy, with a mean price target of $1408.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (8 analysts) rates it buy, with a mean price target of $1408.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (8 analysts) rates it buy, with a mean price target of $1408.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (8 analysts) rates it buy, with a mean price target of $1408.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Quaise Energy secures $134m for Project Obsidian Power Technology · 8 Jul 2026
- Assessing Idemitsu Kosan (TSE:5019) Valuation After Recent Mixed Share Price Performance Simply Wall St. · 3 Apr 2026
- EIG-backed LNG company MidOcean Energy raises $1.2bn in new funding Offshore Technology · 18 Mar 2026
- Idemitsu Kosan (TSE:5019): A Fresh Look at Valuation After Recent Share Price Movements Simply Wall St. · 6 Oct 2025
- Mitsui, Idemitsu, Sumitomo to merge their Japanese plastics operations Just Auto · 12 Sep 2025
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1,360.00 | -2.1% | · | $979 | -2.1% |
| 2 months | $1,544.00 | -13.7% | · | $863 | -13.7% |
| 3 months | $1,423.81 | -6.5% | $18.00 | $948 | -5.2% |
| 6 months | $1,166.33 | +14.2% | $18.00 | $1,157 | +15.7% |
| 1 year | $837.62 | +59.0% | $36.00 | $1,633 | +63.3% |
| 2 years | $1,009.34 | +32.0% | $72.00 | $1,391 | +39.1% |
| 3 years | $519.88 | +156.2% | $104.00 | $2,762 | +176.2% |
| 5 years | $443.04 | +200.7% | $162.00 | $3,372 | +237.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 5019.T does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.